Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER-WaM Pivotal Trial and Waldenstrom’s Macroglobulinemia Market Landscape: https://bit.ly/3XGT53f #pivotaltrial #clinicalresearch #cloverwam #waldenstrommacrocglobulinemia #iopofosine #marketlandscape #KOLEvent
Worth attending
Wasn't data originally supposed to be released by end of June? You guys have, once again, destroyed all shareholder value.
📢 #Probiota Americas 2024 is kicking off today, and ProDigest will be there! 🔗Connect with Bart Roucourt and Peter B. Azmi to discover strategic partnership possibilities that will elevate your R&D pipeline and drive innovation! Partnering with ProDigest will help you to: 📈 𝐎𝐩𝐭𝐢𝐦𝐢𝐳𝐞 𝐅𝐨𝐫𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬: Witness the impact of digestion on your product and get detailed insights, ensuring stability and targeted release. 🔍 𝐔𝐧𝐥𝐨𝐜𝐤 𝐌𝐢𝐜𝐫𝐨𝐛𝐢𝐨𝐦𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: Experience the power of our various in vitro colonic models in exploring the impact of your product on the gut microbiome and vice versa. 💡 𝐒𝐭𝐚𝐲 𝐀𝐡𝐞𝐚𝐝: Benefit from the best-in-class in vitro gastrointestinal simulations and uncover innovative, tailor-made solutions designed to meet your unique needs. #microbiome #guthealth #probiotics #postbiotics #prebiotics #synbiotics #LBP #Probiota
If you are at #bioeuropespring be sure to drop by One Nucleus booth 102B to discuss how CPI can help accelerate your biological therapeutics to market. #BioEuropeSpring #LetsInnovateTogether #CPI #Innovation #Pharma #Upstream #Downstream #Analytical #Formulation #ProcessDevelopment #Microbial #Mammalian #ViralVectors #mRNA #Vaccines #Microbiome #Phage
Come and meet Tony Jones and Jasmin Bannister from One Nucleus along with Inaphaea BioLabs, CPI, Riverlabs, ikarovec , Vernalis, Pharmaron and DefiniGEN on stand 102B at #BIOEuropeSpring in Barcelona this week. Pick up a copy of our new Genesis Review with BIO-Europe Spring highlights or read it here https://bit.ly/3TngK4R
One more day until our webinar with Panalgo where we will look at the scientific and operational details behind study replication, using vitiligo and alopecia areata as an example. Topics covered: ▶️ Vitiligo and alopecia areata landscapes including prevalence, current treatment options, treatments in development, co-occurrence of the two conditions, other comorbid conditions and impact on patients’ quality of life ▶️ Study replication and treatment pathway visualization in Panalgo’s IHD platform ▶️ Richness of OM1 and multi-modal data Register now: https://bit.ly/4asTtFc
Traditionally Arnica montana L. is indicated for treatment of blunt injuries like strains, bruises and contusions that are physiologically accompanied by local inflammation and edema, including activation of the NF-kB pathway and the release of pro-inflammatory prostaglandins and leukotrienes that are produced by cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LO). Arnica flowers (A. flos) contain compounds, e.g. sesquiterpene lactones like helenalin or dihydrohelenalin that are known anti-inflammatory compounds. Join Johann Röhrl, PhD, Senior Manager Preclinical Development, WELEDA UK at this 30-mintue workshop taking place at the IPM Congress on Saturday 8 June, to evaluate the anti-inflammatory efficacy of a hydroethanolic extract from A. flos. Register to attend for just £25 per day. See the full workshop programme online at: https://lnkd.in/d85WNzKi #ipmcongress #integrativemedicine #functionalmedicine #lifestylemedicine #personalisedmedicine #arnica #arnicaflower
Goodbye to 48-hour tests! 👋 At LYOPHITECH, ensuring live cell viability for freeze-dried probiotics is crucial. But regular measurements posed a challenge—until they added BactoBox®. BactoBox® enabled Lyophitech to perform quick measurements, ensuring non-degradation of cell viability. Read the story here: https://lnkd.in/eGuyUY4J Feel free to reach out to our experts for insights on how BactoBox® can benefit your lab too. 🧪 #Bacteria #LabInnovation #Probiotics
Come find our booth during the Lorne Proteins 2024 event to learn how we can support you in achieving your protein research goals! If we don't see each other, you can download the product guide on protein research workflow here: https://lnkd.in/dTPDZQTQ #proteinresearch #AKTA #LORNEPROTEINS
⚫️ Now at ASCRO, Uppsala: Martin Bergstrand explains the possibilities of Model Informed Drug Development, how it can reduce time to market, cost, size of study population and increase probability of success in dose selection, formulation and route of administration among other things, to an engaged audience from different Clinical Research Organizations, (CRO). 🟠 And a tip: There are still (very) few seats left to a workshop on the topic, “An introduction to probabilistic decision support in drug development”, in Rome during PAGE, led by Martin, our CEO Peter Milligan, Chief statistician Richard Anziano and Senior Consultant Giovanni Smania. #cro #lifesciences #biosimulation #biotech
Selecting an inappropriate or less-than-ideal promoter for your custom transgenic model can lead to unexpected issues once the model is available for use. To help avoid such issues, Taconic Biosciences has put together a short guide with advice on how to make an informed decision. Download this white paper to discover how the choice of promoter may have an outsize influence on the performance of your custom transgenic model: https://bit.ly/3XMkvma
amofor is heading to #Barcelona for the 8th SOS Conference next week! The event focus: Latest discoveries and innovations in stability science. Christian Lübbert, Ph.D., will share his insights on stability and #shelflife predictions of #amorphousformulations. Learn more here: 👉 https://lnkd.in/eg3t7SBu We're excited to engage and discuss stability issues in #drugformulations. Stay tuned for more updates from the conference! #ASD #Innovation #AmorphousSolidDispersions
At this year's Macula Society meeting, join #retina specialist Peter Kaiser, MD, as he discusses findings from the Part 1 of the Phase 2/3 SIGLEC study assessing the safety and efficacy of AVD-104 for the treatment of GA. #glycoimmunology #knowga #biotech #innovation #ophthalmology
Hospital pharmacist
1wI’m confident the results will be significantly better that those announced in January. The response seems to deepen with time so I believe the full data release was postpone to give as much time as possible for the response of the last patient to deepens. This technology is very exciting and as a pharmacist, I consider the PDC technology as one of the closest to the perfect drug that I’ve seen. Effective, safe, versatile, easy to administrate with fixed schedule, stable as opposed to other targeted radiotherapeutic, mostly mutation proof. Can’t wait for the 24th of July. Your continued effort guys are about to be a game changer for our patients 🫡